Blogs
Medical Devices-USA/Europe Regulatory…
USA (FDA)
Informed Consent Guidance for IRBs, Clinical Investigators, and Sponsors
The guidance…
Artificial Intelligence in Drug Disco…
The use of Artificial Intelligence (AI) in Medicinal Chemistry has gained significant attention in re…
Avoiding Common Pitfalls: Tips for Co…
The Federal Food, Drug, and Cosmetic Act (FD&C Act) defines cosmetics by their intended…
Pharma Regulatory Intelligence Tools …
Many Organizations are relaying on the Regulatory Intelligence databases due to burden of collecting,…
Medical Devices-USA/Europe Regulatory…
USA (FDA)
Medical Device User Fee Rates for Fiscal Year 2024
The FD&C Act, as amended by MD…
Pharma/Biotech – USA, Europe Re…
US
FY 2024 Biosimilar User Fees Show Sharp Decrease, Other Fees Increase
While prescription dru…
Don’t miss out! Click here to stay in touch.
Categories
- Biopharma (53)
- Consumer Health (15)
- Cosmetics (8)
- Diagnostics (6)
- Digital Health (6)
- Food (1)
- Medical Device (98)
- OTC (3)
- Regulatory Intelligence (5)
- Standards (34)
Most used Tags
Asia Regulatory News (18)
BioTech (10)
Biotech Regulatory News (10)
Compliance (8)
Compliance Management (5)
Consumer Health (8)
EU Regulatory News (10)
Europe Regulatory News (12)
FDA (9)
FDA Updates (5)
Global Compliance (7)
Global Health (6)
Healthcare Industry (6)
IVDR (5)
MDR (5)
medical device labeling requirements (5)
Medical Devices (39)
MHRA (6)
Pharma (11)
Pharma Regulatory News (10)
Regulations (5)
Regulatory Affairs (6)
Regulatory Compliance (9)
Regulatory Intelligence (12)
Regulatory News (36)
Regulatory Updates (34)
ROW Regulatory News (15)
Swissmedic (5)
USA Regulatory News (21)
US FDA (8)